|
WBP4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.238850E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.838600E-01 |
| Normal-vs-Stage2 |
7.242200E-01 |
| Normal-vs-Stage3 |
1.035120E-03 |
| Normal-vs-Stage4 |
4.197100E-03 |
| Stage1-vs-Stage2 |
7.042400E-01 |
| Stage1-vs-Stage3 |
1.395380E-04 |
| Stage1-vs-Stage4 |
1.440720E-03 |
| Stage2-vs-Stage3 |
2.210100E-02 |
| Stage2-vs-Stage4 |
3.352500E-02 |
| Stage3-vs-Stage4 |
8.728600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.311800E-02 |
| Normal-vs-AfricanAmerican |
3.283200E-01 |
| Normal-vs-Asian |
8.350000E-01 |
| Caucasian-vs-AfricanAmerican |
9.044200E-01 |
| Caucasian-vs-Asian |
5.527600E-01 |
| AfricanAmerican-vs-Asian |
5.585000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.339800E-02 |
| Normal-vs-Female |
4.596600E-01 |
| Male-vs-Female |
2.729400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.966210E-02 |
| Normal-vs-Age(41-60Yrs) |
5.811800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.947500E-02 |
| Normal-vs-Age(81-100Yrs) |
4.142400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.176230E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.583600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.986600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.515200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.327400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.342000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.618840E-03 |
| Normal-vs-Grade 2 |
4.631600E-01 |
| Normal-vs-Grade 3 |
7.536200E-03 |
| Normal-vs-Grade 4 |
2.16500000005393E-06 |
| Grade 1-vs-Grade 2 |
4.257900E-02 |
| Grade 1-vs-Grade 3 |
1.411880E-04 |
| Grade 1-vs-Grade 4 |
9.71760000023636E-07 |
| Grade 2-vs-Grade 3 |
1.418160E-04 |
| Grade 2-vs-Grade 4 |
1.38009999983701E-07 |
| Grade 3-vs-Grade 4 |
3.657100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.878500E-03 |
| Normal-vs-ccB subtype |
4.3966999999645E-06 |
| ccA subtype-vs-ccB subtype |
1.7430501486615E-14 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.690400E-02 |
| Normal-vs-N1 |
2.849600E-04 |
| N0-vs-N1 |
4.541600E-02 |
|
|
